EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lang-Lazdunski, L.
Right arrow Articles by Lazdunski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang-Lazdunski, L.
Right arrow Articles by Lazdunski, M.

Eur J Cardiothorac Surg 2000;18:174-181
© 2000 Elsevier Science NL


Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole

Loïc Lang-Lazdunskia, Catherine Heurteauxb, Alexandre Mignonc, Jean Mantzc, Catherine Widmannb, Jean-Marie Desmontsc, Michel Lazdunskib

a Department of Cardiovascular Surgery, Hopital Bichat and Xavier Bichat Medical University, Paris, France
b Institut de Pharmacologie Moléculaire et Cellulaire, CNRS/UPR 411, Valbonne, France
c Department of Anesthesiology, Hopital Bichat, and Xavier Bichat Medical University, Paris, France

Received 20 September 1999; received in revised form 28 February 2000; accepted 7 March 2000.

Corresponding author. Service de Chirurgie Cardio-vasculaire, Centre Hospitalier Universitaire Xavier Bichat, 46 rue henri Huchard, 75018 Paris, France. Tel.: +33-1-4025-8672; fax: +33-1-4025-6700
e-mail: loic.lang{at}wanadoo.fr

Objective: Recent studies confirmed the deleterious role of glutamate in the pathophysiology of spinal cord ischemia induced by aortic cross-clamping. We investigated the effect of riluzole, an anti-glutamate drug, in a rat model of spinal cord ischemia. Materials and methods: Spinal cord ischemia was induced in normothermia for 14 min in Sprague–Dawley rats using direct aortic arch plus left subclavian artery cross-clamping through a limited thoracotomy. Experimental groups were as follows: sham-operation (n=15), control (n=15) receiving only vehicle, riluzole (n=15) receiving riluzole (4 mg/kg) before clamping and at the onset of reperfusion. Separate animals were used for monitoring physiologic parameters in the sham-operation (n=3), control (n=5), and riluzole (n=5) groups. Neurologic status was assessed at 6, 24 h, and then daily up to 96 h. Rats were randomly killed at 24, 48, or 96 h (n=5 for each time). Spinal cords were harvested for histopathology, immunohistochemistry for microtubule-associated protein 2 (MAP-2), TUNEL staining, and analysis of DNA fragmentation by agarose gel electrophoresis. Results: All sham-operated rats had a normal neurologic outcome, whereas all control rats suffered severe and definitive paraplegia. Riluzole-treated rats had significantly better neurologic function compared to the control. Histopathology disclosed severe neuronal necrosis in the lumbar gray matter of control rats, whereas riluzole-treated rats suffered usually mild to moderate injury. Riluzole particularly prevented motor neurons injury. MAP-2 immunoreactivity was completely lost in control rats, whereas it was preserved either completely or partly in riluzole-treated rats. TUNEL staining revealed numerous apoptotic neurons scattered within the whole gray matter of control rats. Riluzole prevented or dramatically attenuated apoptotic neuronal death in treated rats. DNA extracted from lumbar spinal cords of sham-operated and riluzole-treated rats exhibited no laddering, whereas spinal cords from control rats showed DNA laddering with fragmentation into {approx}180 multiples of base pairs. Conclusions: Riluzole may protect the spinal cord in a setting of severe ischemia by preventing neuronal necrosis and apoptosis. This drug may therefore be considered for clinical use during ‘high risk’ surgical procedures on the thoracoabdominal aorta.

Key Words: Riluzole • Spinal cord ischemia • Excitotoxicity • Aorta




This article has been cited by other articles:


Home page
J. Neurosci.Home page
Y. Zhu, P. Fenik, G. Zhan, B. Sanfillipo-Cohn, N. Naidoo, and S. C. Veasey
Eif-2a Protects Brainstem Motoneurons in a Murine Model of Sleep Apnea
J. Neurosci., February 27, 2008; 28(9): 2168 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Voloshyna, A. Besana, M. Castillo, T. Matos, I. B. Weinstein, M. Mansukhani, R. B. Robinson, C. Cordon-Cardo, and S. J. Feinmark
TREK-1 Is a Novel Molecular Target in Prostate Cancer
Cancer Res., February 15, 2008; 68(4): 1197 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. Lang-Lazdunski, J. Bachet, and C. Rogers
Repair of the descending thoracic aorta: impact of open distal anastomosis technique on spinal cord perfusion, neurological outcome and spinal cord histopathology
Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Xing, Y. Zhang, C. R. Stabernack, E. I Eger II, and A. T. Gray
The Use of the Potassium Channel Activator Riluzole to Test Whether Potassium Channels Mediate the Capacity of Isoflurane to Produce Immobility
Anesth. Analg., October 1, 2003; 97(4): 1020 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. S. Isbir, K. Ak, O. Kurtkaya, U. Zeybek, S. Akgun, B. W. Scheitauer, A. Sav, and A. Cobanoglu
Ischemic preconditioning and nicotinamide in spinal cord protection in an experimental model of transient aortic occlusion
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1028 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. A. Peasley and R. Shi
Resistance of isolated mammalian spinal cord white matter to oxygen-glucose deprivation
Am J Physiol Cell Physiol, September 1, 2002; 283(3): C980 - C989.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Lang-Lazdunski, C. Heurteaux, H. Dupont, D. Rouelle, C. Widmann, and J. Mantz
The Effects of FK506 on Neurologic and Histopathologic Outcome After Transient Spinal Cord Ischemia Induced by Aortic Cross-Clamping in Rats
Anesth. Analg., May 1, 2001; 92(5): 1237 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
I. Y.P. Wan, G. D. Angelini, A. J. Bryan, I. Ryder, and M. J. Underwood
Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery
Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 203 - 213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.